Clorox stock holds steady as latest earnings reset guidance
Published on 08/31/2026 at 10:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Clorox Co. (ISIN US1890541097) stock is trading close to $102 per share as of August 28, 2026, after a period of reset in expectations that has left the shares deeply below their prior peak levels. The latest earnings and guidance have become the key reference points for investors weighing the balance between slower growth, margin recovery and cash returns.
Latest share performance and valuation reset
Per a recent market quote snapshot, Clorox stock closed at $102.57 on August 28, 2026, reflecting a marginal gain of $0.04 or 0.04% on the day, with extended trading showing a small dip to $102.38 shortly after the close. That price level places the shares well down from earlier cycle highs, signaling that the market has already priced in a more cautious growth profile.
One performance overview shows Clorox down 47.87% from a prior reference level, indicating how far the valuation has compressed since sentiment was more optimistic. This drawdown illustrates a substantial reset in expectations and positions the shares as a recovery story rather than a momentum play.
Earnings trends and guidance signal
In its most recent reported fiscal period, Clorox delivered a set of results that highlighted a mixed picture: core consumer demand remained resilient in several categories, but margin pressure and cost inflation constrained earnings growth. Revenue for that latest year stayed in the mid-single-digit growth range, while adjusted earnings per share eased as the company absorbed higher input costs and continued brand investment.
Management used the same earnings release to update guidance for the current fiscal year, pointing to a low-to-mid-single-digit percentage increase in sales and a modest improvement in profit margins as cost programs and price actions gain traction. The guidance implies that earnings in the new fiscal year should rise from the prior base, but not at a rate that would immediately restore earlier valuation levels.
Against that backdrop, analysts’ consensus for the current fiscal year centers on a slight year-over-year improvement in earnings per share, reflecting incremental progress rather than a sharp rebound. The combination of soft volume growth, improving mix and disciplined cost control underpins that consensus trajectory.
Comparison with recent performance and expectations
Compared with the previous fiscal year, Clorox’s latest reported numbers show revenue growth of a few percentage points and operating margin that is still below the historical peak range. That gap versus earlier profitability levels underscores how much work remains to fully rebuild earnings power.
The share price around $102 also implies a valuation multiple that is lower than at past peaks, consistent with a market that now discounts slower structural growth. The drawdown of 47.87% from the prior level cited in one performance overview translates into a significantly different risk-reward profile for current holders than in earlier phases when the shares traded much higher.
Investors therefore pay close attention to incremental data points – quarterly revenue growth, EPS progression against guidance, and cash flow trends – to judge whether the earnings recovery is tracking, lagging or improving versus those expectations.
Product focus: Clorox cleaning brands
Clorox’s core business centers on household cleaning and disinfecting products that remain fixtures in many North American homes. Flagship bleach and disinfecting wipes lines anchor the portfolio, supplemented by newer formulations aimed at both convenience and effectiveness. These products tie the company’s financial results closely to patterns in home care spending and to consumer preferences for trusted, branded solutions.
Current market snapshot for Clorox stock
With Clorox stock most recently quoted at $102.57 on August 28, 2026, on the New York Stock Exchange, the shares reflect a market view that recognizes both the defensive qualities of the business and the constraints on near-term growth. The pronounced decline of 47.87% from a prior level in one performance ranking shows that the market has already repriced the stock, leaving potential upside dependent on the company’s ability to deliver on its guidance and gradually restore margins.
Fact box
Company: Clorox Co.
ISIN: US1890541097
Ticker: CLX
Exchange: NYSE
Price (as of August 28, 2026, 3:58 p.m. ET): $102.57 USD
Sector / Industry: Consumer staples / Household products
Index membership: S&P 500
